Cassava Sciences Inc (SAVA)

Nov 23, 2024

Cassava Sciences (NASDAQ:SAVA) Shares Gap DownTime to Sell? - MarketBeat

Nov 23, 2024

Nov 21, 2024

January 2025 Options Now Available For Cassava Sciences (SAVA) - Nasdaq

Nov 21, 2024

Nov 19, 2024

Is Cassava Sciences (SAVA) Outperforming Other Medical Stocks This Year? - MSN

Nov 19, 2024

Nov 18, 2024

Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer - citybiz

Nov 18, 2024

Nov 18, 2024

Cassava Sciences, Inc. Appoints Freda Nassif as Chief Commercial Officer - Marketscreener.com

Nov 18, 2024

Nov 15, 2024

Cassava Sciences stock up on Alzheimer’s update (SAVA:NASDAQ) - Seeking Alpha

Nov 15, 2024

Nov 13, 2024

What Makes Cassava Sciences (SAVA) a New Buy Stock - MSN

Nov 13, 2024

Nov 12, 2024

A High-potential Bull Put Strategy on Cassava Sciences - MSN

Nov 12, 2024

Nov 12, 2024

A High-Potential Bull Put Strategy On Cassava Sciences - Barchart

Nov 12, 2024

Nov 12, 2024

Cassava Sciences Inc (SAVA-Q) QuotePress Release - The Globe and Mail

Nov 12, 2024

Nov 11, 2024

Anavex, Cassava Sciences, Panax Ginseng, And Long-Term Treatment Of Alzheimer's Disease - Seeking Alpha

Nov 11, 2024

Nov 10, 2024

How To Trade (SAVA) - Stock Traders Daily

Nov 10, 2024

Nov 09, 2024

Cassava Sciences, Inc. (NASDAQ:SAVA) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 09, 2024

Nov 09, 2024

Cassava Sciences (NASDAQ:SAVA) Issues Quarterly Earnings Results - MarketBeat

Nov 09, 2024

Nov 09, 2024

Cassava Sciences (NASDAQ:SAVA) Given "Buy" Rating at HC Wainwright - MarketBeat

Nov 09, 2024

Nov 08, 2024

Cassava Sciences Q3 2024 Earnings Preview - MSN

Nov 08, 2024

Nov 08, 2024

Friday's Top 5 Trending Stocks: What's The Scoop On GameStop, SoFi, Tesla? - Benzinga

Nov 08, 2024

Nov 08, 2024

Another U.S. biotech based on Chinese science - STAT

Nov 08, 2024

Nov 08, 2024

Cassava Sciences: With Almost Half The Float Shorted, Results Could Be Interesting - Seeking Alpha

Nov 08, 2024

Nov 08, 2024

Cassava Sciences nears Alzheimer's drug trial results By Investing.com - Investing.com Canada

Nov 08, 2024

Nov 08, 2024

Cassava Sciences’ Q3 2024: Financials and Alzheimer’s Trials Progress - TipRanks

Nov 08, 2024

Nov 07, 2024

Cassava Sciences: Pivotal Alzheimer’s Data May Push Stock Toward Book Value (SAVA) - Seeking Alpha

Nov 07, 2024

Nov 07, 2024

Cassava Q3 Earnings Review: It Feels Like The End May Be Nigh (NASDAQ:SAVA) - Seeking Alpha

Nov 07, 2024

Nov 07, 2024

Looking At Cassava Sciences's Recent Unusual Options Activity - Benzinga

Nov 07, 2024

Nov 07, 2024

Cassava Sciences nears Alzheimer's drug trial results - Investing.com India

Nov 07, 2024

Nov 07, 2024

Cassava Sciences stock in focus after earnings (SAVA:NASDAQ) - Seeking Alpha

Nov 07, 2024

Nov 07, 2024

Cassava Sciences Reports Q3 2024 Financial and Operating Results - The Manila Times

Nov 07, 2024

Nov 06, 2024

Cassava Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 06, 2024

Nov 05, 2024

Cassava Sciences (NASDAQ:SAVA) Trading Down 5.8%Should You Sell? - MarketBeat

Nov 05, 2024

Nov 05, 2024

Unpacking the Latest Options Trading Trends in Cassava Sciences - Benzinga

Nov 05, 2024

Nov 04, 2024

Analysts Believe Cassava Sciences Now Has 300% Upside From Here - MSN

Nov 04, 2024

Nov 01, 2024

Cassava Sciences (SAVA) Scheduled to Post Earnings on Thursday - MarketBeat

Nov 01, 2024

Oct 31, 2024

Cassava Sciences to Report Third Quarter 2024 Results on November 7, 2024 - GlobeNewswire

Oct 31, 2024

Oct 31, 2024

International Assets Investment Management LLC Makes New Investment in Cassava Sciences, Inc. (NASDAQ:SAVA) - MarketBeat

Oct 31, 2024

Oct 30, 2024

Institutions along with individual investors who hold considerable shares inCassava Sciences, Inc. (NASDAQ:SAVA) come under pressure; lose 6.7% of holdings value - Yahoo Finance

Oct 30, 2024

Oct 30, 2024

Long Term Trading Analysis for (SAVA) - Stock Traders Daily

Oct 30, 2024

Oct 26, 2024

HC Wainwright & Co. Upgrades Cassava Sciences (SAVA) - MSN

Oct 26, 2024

Oct 24, 2024

Cassava Sciences Options Trading: A Deep Dive into Market Sentiment - Benzinga

Oct 24, 2024

Oct 21, 2024

Institutions profited after Cassava Sciences, Inc.'s (NASDAQ:SAVA) market cap rose US$72m last week but individual investors profited the most - Simply Wall St

Oct 21, 2024

Oct 19, 2024

(SAVA) Proactive Strategies - Stock Traders Daily

Oct 19, 2024

Oct 17, 2024

Cassava Sciences, Inc. (SAVA): Jim Cramer Says Eli Lilly Has The Edge - Insider Monkey

Oct 17, 2024